共 50 条
- [42] Causes of euglycemic Ketoacidosis under SGLT-2 Inhibitor Therapy DIABETOLOGE, 2019, 15 (05): : 476 - 477
- [46] Safety and effects of SGLT-2 inhibitor use among LVAD patients with type 2 diabetes mellitus AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2022, 18